Literature DB >> 7327166

The action of three anticlastogens on the induction of sister chromatid exchange by trenimon and 8-hydroxyquinoline sulfate in human lymphocyte cultures.

E Gebhart, H Kappauf.   

Abstract

The influence of the anticlastogens beta-aminoethylisothiouronium (AET), d,l-homocysteinethiolactone (HCT), and 1-cysteine (CYS) on the frequency of sister chromatid exchanges (SCEs) induced by the chromosome damaging chemicals Trenimon and 8-hydroxyquinoline sulfate (8-HQS), was investigated in human lymphocyte cultures. None of the anticlastogens significantly influenced the SCE rate, whereas in the same or previous experiments the chromosome-breaking effect of these clastogens was distinctly reduced by the anticlastogens. These results suggest that the sites of anticlastogenic activity do not coincide with the sites of SCE formation. SCE analysis, although it yields interesting and important information about the action of chemicals on genetic material, cannot replace classical aberration analysis, because the two parameters apparently reflect different patterns of molecular and cytogenetic activity of mutagens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7327166     DOI: 10.1002/em.2860020212

Source DB:  PubMed          Journal:  Environ Mutagen        ISSN: 0192-2521


  3 in total

Review 1.  Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing.

Authors:  E Gebhart
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

2.  Chromosome studies on lymphocytes of patients under cytostatic therapy. II. Studies Using the BUDR-labelling technique in cytostatic interval therapy.

Authors:  E Gebhart; B Windolph; F Wopfner
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

3.  Effects of Thymus kotschyanus var. glabrescens Boiss. extract on mitomycin-C induced chromosomal aberrations and sister chromatid exchanges in human lymphocytes.

Authors:  Mustafa Celik; Fatma Unal; Deniz Yüzbaşıoğlu; Serkan Yılmaz; Hüseyin Aksoy; Sengül Karaman
Journal:  Cytotechnology       Date:  2006-09-21       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.